Reneo Pharmaceuticals, Inc.
RPHM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$52,673 | -$77,388 | -$51,955 | -$39,770 |
| Dep. & Amort. | $662 | $170 | $88 | $50 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,530 | $5,112 | $4 | $4 |
| Change in WC | $0 | $12,218 | $959 | -$2,800 |
| Other Non-Cash | -$3,636 | -$3,794 | -$774 | $646 |
| Operating Cash Flow | -$51,117 | -$63,682 | -$47,362 | -$37,983 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$52 | -$221 | -$346 | -$198 |
| Net Acquisitions | $0 | $0 | $57 | $23 |
| Inv. Purchases | $0 | -$231,257 | -$101,596 | -$31,406 |
| Inv. Sales/Matur. | $15,925 | $242,000 | $44,100 | $8,228 |
| Other Inv. Act. | $0 | $0 | -$57 | -$23 |
| Investing Cash Flow | $15,873 | $10,522 | -$57,842 | -$23,376 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $58,881 | $64,538 | $193 | $84,612 |
| Stock Repurch. | $0 | -$4,403 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $116,129 | $730 | $278 | $47,794 |
| Financing Cash Flow | $116,129 | $60,865 | $471 | $132,406 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $80,885 | $7,705 | -$104,733 | $71,047 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,876 | $19,927 | $124,660 | $53,613 |
| End Cash | $110,761 | $27,632 | $19,927 | $124,660 |
| Free Cash Flow | -$51,169 | -$63,903 | -$47,708 | -$38,181 |